Drug recall

Vial label: nocita (bupivacaine liposome injectable suspension), 13.3 mg/mL, [10mL or 20mL] Single use vial…

FDA recall event 97980 · Class II · ELANCO US INC

Key facts

Event ID 97980
Recall numbers V-0023-2026, V-0024-2026
Recalling firm ELANCO US INC
Product type Veterinary
Products Vial label: nocita (bupivacaine liposome injectable suspension), 13.3 mg/mL, [10mL or 20mL] Single use vial, Manufactured for: Elanco US Inc., Indianapolis, IN 46221 USA. Box label: nocita…, Vial label: onsior (robenacoxib) injection, 20 mg/mL Carton label: onsior (robenacoxib) injection, 20 mg/mL, 1 multi-dose vial, Manufactured for: Elanco USA Inc., Greenfield, IN 46140
Classification Class II
Status Ongoing
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Temperature Abuse
Initiation date Nov 14, 2025
Report date Dec 10, 2025
City Indianapolis
State IN
Country United States
FEI number 3012761605

At a glance

  • 1–9 Products in this recall
  • 1–9 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls